OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(25)
Release Date
2022
(4)
2021
(4)
2014
(3)
2012
(3)
2023
(2)
2017
(2)
2013
(2)
2025
(1)
2024
(1)
2020
(1)
2016
(1)
2010
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
Not available
S-EPMC3494835
|
biostudies-literature
Cite
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
Not available
S-EPMC3757290
|
biostudies-literature
Cite
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
Not available
S-EPMC3478574
|
biostudies-literature
Cite
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
Not available
S-EPMC5721228
|
biostudies-literature
Cite
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Not available
S-EPMC5545896
|
biostudies-literature
Cite
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Not available
S-EPMC2935331
|
biostudies-literature
Cite
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.
Not available
S-EPMC3558410
|
biostudies-literature
Cite
Past Decline Versus Current eGFR and Subsequent Mortality Risk.
Not available
S-EPMC4978054
|
biostudies-literature
Cite
Age and association of kidney measures with mortality and end-stage renal disease.
Not available
S-EPMC3936348
|
biostudies-literature
Cite
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.
Not available
S-EPMC4172342
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets